The Company said in a filing before the Securities and Exchange Commission that its total revenue for the year was $726.4 million
Based in SAN DIEGO, California, ACADIA PHARMACEUTICALS INC operates in the MANUFACTURING sector.
In the fiscal year ending December 31, 2023, Company XYZ reported total revenues of $726.4 million, showing an increase from the previous year's revenue of $517.2 million in 2022 and $484.1 million in 2021.
The cost of product sales for the year 2023 amounted to $41.6 million compared to $10.2 million in 2022 and $19.1 million in 2021. Research and development expenses were $351.6 million in 2023, slightly lower than the $361.6 million recorded in 2022 but higher than the $239.4 million in 2021. Selling, general, and administrative expenses totaled $406.6 million in 2023, up from $369.1 million in 2022 and slightly below the $396.0 million in 2021.
The company reported a loss from operations of $73.4 million in 2023, a significant improvement from the loss of $223.6 million in 2022 and $170.4 million in 2021. Interest income net increased to $17.2 million in 2023 from $6.6 million in 2022 and $0.6 million in 2021. Other income also showed growth, reaching $5.1 million in 2023 compared to $3.5 million in 2022 and $2.3 million in 2021.
After accounting for income tax expenses, Company XYZ reported a net loss of $61.3 million in 2023, a decrease from the net loss of $216.0 million in 2022 and $167.9 million in 2021.
The basic and diluted net loss per common share were $0.37 in 2023, an improvement from $1.34 in 2022 and 2021. The weighted average common shares outstanding for the year were 163.8 million in 2023, 161.7 million in 2022, and 160.5 million in 2021.
Note: All dollar amounts are represented in millions.
USInMinutes/IndiaInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to more news alerts here. Although care is taken to ensure accuracy of the data, the article does not intend to replace user diligence while taking decisions of financial or legal implications